Waksman acquires PacBio Sequel DNA Sequencer

With generous support from Chancellor of Rutgers New Brunswick, we are pleased to announce the acquisition of a PacBio Sequel DNA sequencer. The Sequel uses Single Molecule Real Time (SMRT) technology to produce long reads, uniform coverage, and high consensus accuracy. The Sequel long 10-15kb reads are ideal for whole genome sequencing, full-length transcript sequencing, or sequencing of long amplicons. Additionally, its SMRT sequencing technology can also be used to directly detect DNA base modifications.

The Sequel will complement our other short read sequencing instrument Illumina MiSeq and NExtSeq.

If you are interested please contact Dibyendu Kumar at dk'at'waksman.rutgers.edu